Adamas Pharmaceuticals, Inc. logo
Adamas Pharmaceuticals, Inc. ADMS
$ 8.22 0.0%

Adamas Pharmaceuticals, Inc. Income Statement 2011-2024 | ADMS

Annual Income Statement Adamas Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

164 M 141 M 239 M 886 M 323 M 310 M 250 M - - -

Shares

27.7 M 27.7 M 26.9 M 22.6 M 21.7 M 18.1 M 14.8 M - - -

Net Income

-57.4 M -105 M -131 M -89.5 M -60.1 M -51.8 M 10.2 M 50.9 M 17.7 M -

Revenue

74.5 M 54.6 M 34 M 571 K 572 K 1.92 M 55.8 M 71.1 M 37.5 M -

EBITDA

-43.3 M -91 M -114 M -86.7 M -60.2 M -57 M 18.7 M 57.1 M 20 M -

Operating Expenses

117 M 144 M 148 M 88.5 M 61.6 M 59.4 M 37.3 M 14.1 M 17.5 M -

General and Administrative Expenses

107 M 114 M 109 M 61.3 M 30.3 M 23.5 M 15.5 M 6.67 M 8.33 M -

All numbers in USD currency